NAGE
ナイアジェン・バイオサイエンス
Niagen Bioscience Inc
閉場中20日平均DV $3M?
Earnings 2026-08-0552W high -76.5%52W low +3.0%PER 29.0xFwd PER 15.1xMarket cap $275MAvg volume 859K
Company Overview
Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2026 Q1 | 0.08 | $31M | -$1M |
| 2025 Q4 | 0.05 | $34M | $523,000 |
| 2025 Q3 | 0.06 | $34M | $4M |
| 2025 Q2 | 0.05 | $31M | $1M |
| 2025 Q1 | 0.07 | $30M | $8M |
| 2024 Q4 | 0.09 | $29M | $9M |
| 2024 Q3 |
